Abstract 235: AXL inhibition leads to a reversal of a mesenchymal phenotype sensitizing cancer cells to targeted agents and immuno-oncology therapies

Title
Abstract 235: AXL inhibition leads to a reversal of a mesenchymal phenotype sensitizing cancer cells to targeted agents and immuno-oncology therapies
Authors
Keywords
-
Journal
CANCER RESEARCH
Volume 76, Issue 14 Supplement, Pages 235-235
Publisher
American Association for Cancer Research (AACR)
Online
2016-07-27
DOI
10.1158/1538-7445.am2016-235

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More